End-of-day quote
NSE India S.E.
03:30:00 31/05/2024 am IST
5-day change
1st Jan Change
1,907
INR
-0.71%
-3.25%
+13.62%
Sales 2024
12.08B
145M
Sales 2025 *
13.6B
163M
Capitalization
97.68B
1.17B
Net income 2024
1.28B
15.32M
Net income 2025 *
1.77B
21.23M
EV / Sales 2024
7.31
x
Net cash position
2024
*
1.08B
12.9M
Net cash position
2025
*
2.2B
26.37M
EV / Sales 2025 *
7.02
x P/E ratio 2024
69.3
x
P/E ratio 2025 *
54.7
x
Employees
4,300
Yield 2024 *
0.51%
Yield 2025 *
0.57%
Free-Float
50.33%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Metropolis Healthcare Limited to Seek Acquisitions
22/05
CI
Transcript : Metropolis Healthcare Limited, Q4 2024 Earnings Call, May 22, 2024
22/05
Metropolis Healthcare Limited Appoints Sushil Shah as Chairman Emeritus, Effective May 22, 2024
21/05
CI
Metropolis Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
21/05
CI
Metropolis Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2024
21/05
CI
Metropolis Healthcare Limited Receives Notice from the Anti-Corruption Branch, New Delhi
12/05
CI
India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand
10/05
RE
Metropolis Healthcare Books 10% Increase in Fiscal Q4 Overall Revenue
11/04
MT
Metropolis Healthcare Limited Announces Consolidated Revenue Results for the Fourth Quarter Ended March 31, 2024
10/04
CI
Metropolis Healthcare's Consolidated Net Profit Declines in Fiscal Q3
05/02
MT
Transcript : Metropolis Healthcare Limited, Q3 2024 Earnings Call, Feb 05, 2024
05/02
Metropolis Healthcare Limited Announces Management Changes
02/02
CI
Metropolis Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
02/02
CI
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests
01/02
RE
Transcript : Metropolis Healthcare Limited, Q2 2024 Earnings Call, Nov 06, 2023
06/11
More news
1 day -0.71%
1 week -3.25%
1 month +5.37%
3 months +12.22%
6 months +12.95%
Current year +13.62%
More quotes
Managers
Title Age Since
Chief Executive Officer
-
02/23/02
Director of Finance/CFO
-
11/19/11
President
-
01/87/01
Members of the board
Title Age Since
Director/Board Member
69
14/20/14
Chairman
44
01/08/01
Director/Board Member
58
01/18/01
More insiders
Date
Price
Change
Volume
31/24/31
1,907
-0.71%
182,109
30/24/30
1,920
-2.58%
172,571
29/24/29
1,971
-1.17%
101,473
28/24/28
1,995
+0.87%
170,782
27/24/27
1,977
+0.33%
382,342
End-of-day quote
NSE India S.E., May 31, 2024
More quotes
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.
More about the company
Last Close Price
1,907
INR
Average target price
1,841
INR
Spread / Average Target
-3.44%
Consensus
1st Jan change
Capi.
+13.62% 1.17B -23.78% 7.76B +68.65% 4.33B -2.98% 2.64B +2.72% 2.63B -46.17% 2.16B -15.27% 1.75B -22.12% 1.46B -43.81% 1.14B +20.41% 999M
Medical & Diagnostic Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1